Plain-English translation of NCT07303257 on ClinicalTrials.gov ↗ ·
This study is evaluating how different types of glaucoma surgery—including Preserflo MicroShunt with mitomycin C, trabeculectomy with mitomycin C, and non-penetrating deep sclerectomy with mitomycin C—affect patients' quality of life and day-to-day experiences. Instead of only measuring clinical success (like eye pressure reduction), the researchers want to understand how patients actually feel and function after surgery, including during the recovery and follow-up period.
Doctors have traditionally judged glaucoma surgery success only by objective measurements like eye pressure lowering. However, what matters most to patients is how surgery affects their real life—their vision, activities, and emotional well-being. This study exists to fill that gap and help doctors better understand and support patients through surgery and recovery.
You likely qualify if…
You likely don't qualify if…
You would receive one of three types of glaucoma surgery as recommended by your eye doctor. Over the next six months, you would attend follow-up visits where doctors check your eye pressure and eye health, and you would complete questionnaires about how you're feeling, your vision, and how surgery has affected your daily activities and quality of life. The study collects both your medical data and your personal perspective on recovery and well-being.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France